Other studies have suggested that the prognosis of mutated RUNX1 AML is context dependent, with worse outcomes observed mainly in patients with ASXL1, SRSF2, and/or PHF6 co‐mutations [12]. The gene discussed is SRSF2; the disease is acute myeloid leukemia.